The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

For the third straight year, The Mount Sinai Hospital is ranked the top hospital in New York State on Newsweek/Statista's "World's Best Hospitals" list for 2025. The Mount Sinai Hospital moved up ...

The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...